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Abstract Background FAIR (findability, accessibility, interoperability, and reusability) guiding
principles seek the reuse of data and other digital research input, output, and objects
(algorithms, tools, and workflows that led to that data) making them findable, accessible,
interoperable, and reusable. GO FAIR - a bottom-up, stakeholder driven and self-governed
initiative - definedaseven-stepFAIRificationprocess focusingondata, but also indicating the
required work for metadata. This FAIRification process aims at addressing the translation of
raw datasets into FAIR datasets in a general way, without considering specific requirements
and challenges that may arise when dealing with some particular types of data.
Objectives This scientific contribution addresses the architecture design of an open
technological solution built upon the FAIRification process proposed by “GO FAIR” which
addresses the identified gaps that such process has when dealing with health datasets.
Methods A common FAIRification workflow was developed by applying restrictions
on existing steps and introducing new steps for specific requirements of health data.
These requirements have been elicited after analyzing the FAIRification workflow from
different perspectives: technical barriers, ethical implications, and legal framework.
This analysis identified gaps when applying the FAIRification process proposed by GO
FAIR to health research data management in terms of data curation, validation,
deidentification, versioning, and indexing.
Results A technological architecture based on the use of Health Level Seven
International (HL7) FHIR (fast health care interoperability resources) resources is
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Introduction
The FAIR (findability, accessibility, interoperability, and re-
usability) data principles were first published in 2016.1 FAIR
seeks the reuse of data and other digital research output and
objects (algorithms, tools, and workflows that led to that
data) making them findable, accessible, interoperable, and
reusable. These principles consider applications and compu-
tational agents as stakeholders with the capacity to find,
access, interoperate, and reuse data with none or minimal
human intervention. They also recognize the importance of
an automated process for computational support to dealwith
intensive data processes. As stated byMons et al,2 FAIR refers
to a set of principles, focused on ensuring that research
objects are reusable, are actually reused, and in this way
become as valuable as is possible. They deliberately do not
specify technical requirements but deliver a set of guiding
principles that provide for a continuum of increasing reus-
ability, via many different implementations. They describe
characteristics and aspirations for systems and services to
support the creation of valuable research outputs that could
then be rigorously evaluated and extensively reused, with
appropriate credit, to the benefit of creators and users.
The first draft of the FAIR data principles was born in
January 2014 at the Lorentz Center in Leiden, theNetherlands,
by a community of scholars, librarians, archivists, publishers,
and research funders as a part of the Future of Research and
Communications and e-Scholarship group (FORCE11, https://
www.force11.org/). As early as July 2016, the European Union
(EU) published the Guidelines on FAIR data management in
Horizon 2020.3 The principles are also explicitly mentioned in
thenewopendataandreusablepublic sector information (PSI)
directive,4 and the European Open Science Cloud (EOSC)
focuses on enabling FAIR data and principles. In the United
States, the National Institutes of Health (NIH) also support the
FAIR principles5 and it can be said that the most important
research funding agencies and international organizations
support or have adopted these principles.
Among ongoing initiatives addressing the application of
FAIRdataprinciples inpractice,GOFAIR is aprominentone.GO
FAIR is a bottom-up, stakeholder-driven, and self-governed
initiative that aims to implement the FAIR data principles. It
offers an open and inclusive ecosystem for individuals, insti-
tutions and organizations working together through imple-
mentation networks (INs).6 The FAIR data principles apply not
only to data, but also to metadata, supporting infrastructure
(e.g., search engines) and other research outputs. At the
metadata level, findability and accessibility requirements
must be addressed, while interoperability and reuse require
more efforts at the data level. GO FAIR defined a seven-step
FAIRification process7 focusing on data, but also indicating the
required work for metadata alignment. The FAIRification
process was conceived as a set of step-by-step operations
that should be performed over data and related metadata to
achieve its FAIRness. According to GO FAIR, the steps involved
in this process are as follows: (1) retrieve non-FAIR data, (2)
analyze the retrieved data, (3) define the semantic model, (4)
make data linkable, (5) assign license, (6) define metadata for
the dataset, and (7) deploy/publish FAIR data resource.
This FAIRification process aims at addressing the transla-
tion of raw datasets into FAIR datasets in a general way,
without considering specific requirements, and challenges
that may arise when dealing with some particular types of
data, such ashealthdata. Beyond the technical interoperability
challenges of connecting various information systems and
using analytical methodologies able to cope with the growing
amount of data, managing and reusing health data also poses
significant challenges from ethical, legal, and privacy points of
view.8–10 Furthermore, these issues are usually interwoven
and must be tackled with a common strategy.
Ethical considerations for health research commonly rely
on the World Medical Association (WMA) Declaration of
Helsinki—Ethical Principles for Medical Research Involving
HumanSubjects (revised2014).11Recently, theWMA released
the Declaration of Taipei on Ethical Considerations regarding
Health Databases and Biobanks12 to address ethical issues
derived from reusing health data beyond its original purpose
(i.e., for research and innovation, mainly). To comply with this
declaration when reusing health data, reasonable efforts to
obtain voluntary and informed consent must be sought, and
dignity, autonomy, privacy, and confidentiality of patients
must be protected among other considerations. To cope with
these ethical principles, national regulations have been devel-
oped in the last years. In the United States, the Health Insur-
ance Portability and Accountability Act (HIPAA) first released
in 1996 and then amended in 2009 through the Health
Information Technology for Economic and Clinical Health
(HITECH) Act,13 provides the legal framework for individuals
and health professionals about health information privacy.
HIPAA contemplated that most research would be conducted
Discussion Research funding agencies all over the world increasingly demand the
application of the FAIR guiding principles to health research output. Existing tools do
not fully address the identified needs for health data management. Therefore,
researchers may benefit in the coming years from a common framework that supports
the proposed FAIRification workflow applied to health datasets.
Conclusion Routine health care datasets or data resulting from health research can
be FAIRified, shared and reused within the health research community following the
proposed FAIRification workflow and implementing technical architecture.
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by universities and health systems, but today much of the
demand for data emanates from private companies at which
ethical review boards (ERBs) and privacy boards may be
weaker or nonexistent.14Moreover, the increasing availability
of data generated outside health care settings, coupled with
advances in computing, undermines thehistorical assumption
that data can be forever deidentified.15 In the EU, the General
DataProtectionRegulation (GDPR)16entered into force in2018
and prevails over potentially clashing national regulations.
GDPR sets forth a set of principles that must be followedwhen
processing personal information: (1) lawfulness, fairness, and
transparency; (2) purpose limitation; (3) data minimization;
(4) accuracy; (5) storage limitation; and (6) integrity and
confidentiality. Besides, it enforces compliance with account-
ability by encouraging good practices, such as implementing
data protection policies and security mechanisms, document-
ing any processing activity, and carrying out data protection
impact assessments, among others. Nonetheless, if at some
point, it is possible to achieve total anonymization that would
guarantee the absolute impossibility of reidentifying the data
subject, anonymized data would cease to have the status of
personal data under the GDPR perspective. It would therefore
bepossible toprocesssuchdatawithouthaving tocomplywith
the data protection requirements.
However, patient privacy is not the only challenge when
processing health data for a secondary use. Extracting struc-
tured and accurate information from unstructured reports,
such as narrative sections in electronic health records (EHRs),
is a common challenge when performing research over big
cohorts of subjects within the Natural Language Processing
(NLP) domain.17 However, NLP performance highly depends
on the study objective, clinical domain and language,18–20 and
therefore, although promising, it is still far from the general
application in clinical settings.
The FAIRification process7 supported by GO FAIR was
developed considering data management needs derived
from research outputs to optimize their reusability. Health
research datasets are commonly static in the sense that they
represent the status of a sample or patient at specific time
points, usually before and after the application of an interven-
tion, to observe its impact on the sample or patient. This
argument is not valid when researchers want to reuse health
data gathered for other purposes, such as routine care, since
this type of data are not gathered during scheduled consulta-
tions but under the continuum of health care delivery. How to
appropriately manage the update and versioning of these
datasets in a research environment is still an open issue.21–23
Objectives
The overall objective of this work is to encourage the health
research community to FAIRify, share and reuse their datasets
derived from publicly funded activities (both research and
health care) by facilitating the FAIRification process, and
demonstrating the potential impact of such strategy on health
outcomes and health research. In line with this objective, an
intuitive, user-centered technological solution is being devel-
oped to enable the transformation of raw datasets into FAIR
datasets. These datasets can be gathered from different sour-
ces, such as specific collections of health research data, EHRs,
personal health records (PHRs), as well as other datasets
addressing health, social, and environmental determinants,
among others.
In this context, this paper presents the architecture design
of an open technological solution built upon the FAIRification
process proposed by GO FAIR closing the gaps of this process
for health datasets, thus providing the health research com-
munity with a common, standards-based, legally-compliant
FAIRification workflow for health data management. The
actual implementation of the proposed architecture has
been initiated as an open-source activity (https://github.
com/fair4health), developing a set of software tools address-
ing different steps of the FAIRification workflow.
Methods
This work adapts the FAIRification process introduced by GO
FAIR to health data and proposes a common FAIRification
workflow by applying restrictions on existing steps and intro-
ducing new steps for specific requirements of health data.
These requirements have been elicited after analyzing the
needs that such a FAIRification workflow may have from
different perspectives: technical barriers, ethical implications,
and legal framework. The analysis of technical barriers was
based on the conclusions extracted by a focus group of experts
after discussing about the conclusions reached by Wilkinson
et al24 and the “turning FAIR into reality” high level expert
group report.25 The analysis of ethical implications follows the
conclusions of a focus group that reviewed the results of an
open survey.26–30 Finally, a comprehensive review of the EU
GDPR andnational legislations in Spain, Italy, Switzerland, and
Serbia, in thecontextof FAIR4Healthproject,31wasperformed.
The revision included the following regulations:
• EU: regulation 2016/679 of the European Parliament and
of the Council of April 27, 2016 on the protection of
natural persons with regard to the processing of personal
data and on the freemovement of such data, and repealing
directive 95/46/EC.
• Italy: legislative decree no. 196/2003, containing the
“code for the protection of personal data”; General autho-
rization no. 9/2016 to process personal data for scientific
research purposes; general authorizations no. 1/2016,
3/2016, 6/2016, 8/2016, and 9/2016 that are compatible
with the regulation and legislative decree no. 101/2018;
deontological rules for statistical or scientific research
treatments, no. 515/2018.
• Serbia: law 87/2018–54 on personal data protection.
• Spain: organic law 3/2018, of 5 December, on the protec-
tion of personal data and the guarantee of digital rights;
law 14/2007, of 3 July, on biomedical research; law
33/2011, of 4 October, general public health.
• Switzerland: data protection framework in CH; Federal
Act data protection; Federal Data Protection and Informa-
tion Commissioner (FDPIC); the Human Research Act
(HRA).
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• As a result of the comprehensive analysis performed, this
paper introduces the proposed FAIRification workflow
tailored to the specific needs and requirements posed
by the use of health data as shown in ►Fig. 1. Blue boxes
(1,4,5,6,9,10) come from the GO FAIR process and this
paper proposes restricted actions for those steps, while
the green boxes (2,3,7,8) are newly introduced steps to
meet the specific challenges of health data, such as health
data curation bearing the clinical concepts in mind, and
highly sensitive nature of health data.
Raw Data Analysis
The raw data analysis inspects the content of the data to find
out which concepts are represented, what is the structure
within and among the data element concepts, andwhich is the
storage and serialization format of the data elements. At this
step, analyzing health data requires extra intervention first to
take theclinicaldatamodels into account. In thisdomain, there
are several standardization efforts for health data manage-
ment, for example, research data to be repurposed for future
studies are expected to conform to clinical data standards.
Hence, this step should be aware of the well-established and
widely used standards in clinical care and clinical research
such as Health Level Seven International (HL7) clinical docu-
ment architecture (CDA),32HL7 fast health care interoperabili-
ty resources (FHIRs),33OpenEHR,34 andobservationalmedical
outcomes partnership (OMOP) common data model (CDM).35
In addition to data modeling, health data utilizes several
coding schemes and terminology systems which needs to be
considered during the raw data analysis step.
Data Curation and Validation
This step is directed toward increasing the quality of the
dataset for research purposes. This step may be of little help
for raw datasets coming from research, which are usually
well curated. However, health data extracted from routine
care usually need to be repurposed and validated to be useful
for research. During data curation, data fields, types, and
values (metadata) are characterized, and clinical concepts,
such as data elements or fields for diagnostics, medications,
laboratory results, etc., are extracted. The curated data
should be validated against knownquantitative relationships
and expected values and should conform to semantic model
(step 4) defined for the FAIRification workflow, that is, the
predefined target data model through a set of structural
rules. Moreover, the data itself (i.e., the value of a systolic
blood pressuremeasurement) should conform to the seman-
tic rules exposed by the data element or attribute itself.
Data Deidentification and Pseudonymization
Once the dataset is curated, validated, and has relevant
metadata aggregated, the next step would be to deidentify
and/or pseudonymize the dataset to enable its sharing
without comprising the data subjects’ rights regarding pri-
vacy issues (Cf. 3.4.2, GDPR). The decision to apply deidenti-
fication and/or pseudonymization to the dataset will depend
on the purpose for which the dataset has been developed. For
instance, in case there is a need to update the dataset from
time to time as more data from the same data subjects are
available, pseudonymization techniques, such as one-way
encryption of identifiers, could be applied. Specific registries
could be located and updated with new informationwithout
disclosing sensitive information in the process.
Deidentification techniques could be developed based on
the HIPAA deidentification Standard of Protected Health
Information36 that identifies data types that should be
dropped from a health dataset to minimize the risk of
reidentification of data subjects.
Pseudonymization techniques can be based on replacing
personal identifiers with artificial identifiers or pseudonyms.
This isusually performedoverdata subjects’unique identifiers,
such as national/passport ID number and health ID number
Thispseudonymalongwith the rest of personal identifiers (full
name, telephone number, address, etc.) is stored in a separate
file. To this end, there are multiple one-way encryption algo-
rithmsthatcouldbeapplied, suchas theSecureHashAlgorithm
(SHA-x).37,38 It should be noted that, although nowadays one-
way encryption algorithms are considered secure, they all are
Fig. 1 The FAIRification workflow for health data. The blue boxes come from the GO FAIR (an initiative implementing FAIR data principles)
process, while the green boxes are newly introduced steps to meet the specific challenges of health data. FAIR, findability, accessibility,
interoperability, and reusability.
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exposed tobrute force attackswhichwill becomemore feasible
as information technologies evolve and greater processing
capacity is made available to the general public.
Apart from deidentification of directly identifying attrib-
utes, such as patient IDs and names, deidentification of other
elements of the datasets that may act as quasi-identifiers,
such as dates (such as birth, death, admission, discharge,
visit, and specimen collection), locations (such as postal
codes, hospital names, and regions), race and ethnicity,
and in some cases rare diagnoses, should be addressed as
well. Different methods for deidentification, such as fuzzing
(adding “noise” to an atomic data element), generalization
(making an atomic data element less specific and longitudi-
nal consistency (modifying data so that it is shifted by a
specific amount), can be considered for these quasi-
identifiers.39
Semantic Modeling
This step involves defining a “semantic model” for the data-
set, which describes the meaning of entities and relations in
the dataset accurately, unambiguously, and in a computer-
actionable way. Depending on the dataset, defining a proper
semantic model may require a significant effort, even for
experienced data modelers. A good semantic model should
represent a consensus view in a particular domain, for a
particular purpose. Therefore, it is good practice to comply
with existing models that are resulting from standardization
efforts. Data curation shouldmap the raw data conforming to
such a standard-based data model. In the health domain, in
addition to datamodel standards likeHL7 CDA,32HL7 FHIR,33
or OMOP CDM,35 there are widely used vocabularies for
health-related terms. The semantic model for the dataset
should incorporate vocabularies, terminology systems, cod-
ing standards such as International Classification of Disease
(ICD),40 Systematized Nomenclature of Medicine Clinical
Terms (SNOMED CT), and 41 Logical Observation Identifiers
Names and Codes (LOINC).42.
Make Data Linkable
Raw data can be transformed into linkable data by applying
the semantic model defined in the previous step. Currently,
this is done using semanticweband linkeddata technologies.
This step promotes interoperability and reuse, facilitating
the integration of the data with other types of data and
systems. However, the user should evaluate the feasibility of
this step for the given dataset. It is a sensible thing to do for
many types of data (e.g., structured data), but it may not be
relevant for other types (e.g., the pixels in images).
License Attribution
The use of licensing attributions applied to health datasets
must be subject to the regulatory framework in force for each
data owner, especially when it comes to sensitive data. The
importance of setting clear license terms is required for
reusability of the dataset. Therefore, the license attribution
for the dataset should be stated clearly, as well as the process
by which an external requester could request permission to
reuse the dataset.
Data Versioning
The Research Data Alliance (RDA) Working Group on data
citation released a set of 14 recommendations regarding data
versioning43 to enable precise identification of every subset
and version of data used, supporting reproducibility of
processes, sharing and reuse of data. Data versioning should
be handled following the international standards, best prac-
tices, and recommendations such as those of RDA. The
standard recommended for data versioning is the Reference
Model for an Open Archival Information System (OAIS), ISO
14721:2003.44 The reference model embraces six entities
and three information packages, which have been used
previously toward the design of a repository for standardized
medical image and signal case data annotated with ground
truth45:
1. Ingest: the first stage of OAIS includes the receipt of
submission information package (SIP) that is created
and submitted by the producer (user or system),
and recording of data provenance in archival informa-
tion package (AIP), which is sent to the persistence
archive.
2. Archival storage: in this step, semantic enrichment and
linking of data are handled and fed back into the AIPs.
3. Data management: the OAIS model has a component for
administering the database and performing queries. This
component is enhanced with data privacy mechanisms
and deidentification procedures, applicable when health
data are processed. Altogether, ingest, archival storage,
and data management make sure that FAIR data are
generated.
4. Preservation planning: this OAIS component is designed
to ensure long-term accessibility of data. The persistent
archive holds a history change log, particularly including
the versioning of data, and all information required to
recreate any dissemination information package (DIP)
that has been created previously.
5. Access: as the data and metadata such as annotations are
subject to modifications within their full lifetime span,
the user can loop a modified DIP back as SIP, where the
next ingest step includes a versioning of data. This step
ensures reproducibility on any experimental dataset that
has been delivered in the past.
6. Administration: the last OAIS component is related to the
overall operation of FAIR data and includes, for instance,
agreements with data producers and consumers.
Indexing
Indexing is an important step for the health data since
searching over these datasets is one of the ultimate goals of
FAIRification. Especially for the secondary use of health
data, executing eligibility queries over a population, or
querying individual records of a single patient is crucial.
Each versioned data needs to be indexed with respect to the
possible search parameters over the records. HL7 FHIR
provides an inherent functionality for configuring the
search parameters on the resource types and this step
utilizes this capability of FHIR with the design of data
versioning.
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Metadata Aggregation
This action is performed to state the dataset data provenance,
increase its quality, and understandability, thus enabling its
findability and reusability in further research studies. There
are many metadata standards and vocabularies already avail-
able to the scientific community. However, ametadata schema
for clinical research in general based on the DataCite standard
has been published by researchers from the European Clinical
Research Information Network (ECRIN) group addressing the
general needs that health researchprojects have in common.46
This schema should serve as a starting point for those public
health care providers and health researchers wishing to FAIR-
ify their datasets for research purposes.
Publishing
Data publishing is the process ofmaking FAIR health datasets
available to a separate storage device for long-term
retention/preservation. For health datasets, this is not a
trivial issue, since data types and sizes may hugely vary
depending on the original sources. Publishing datasets in an
external repository does not imply making the data open,
given that some repositories make datasets available under
licenses similar to the “on demand, upon approval.”
Results
The FAIRification workflow presented in this paper is
designed by focusing on the specific needs and requirements
of health data. Any system aiming to transform raw health
data into FAIR health data should provide effective solutions,
especially for the newly introduced steps in the workflow. In
this regard, in this section, we present an architecture
(►Fig. 2) that meets the challenges exposed by our newly
introduced steps within the FAIRification workflow. The
remaining ones (GO FAIR steps) can be implemented through
organization-wide business processes and adopting health-
specific software frameworks.
As depicted in ►Fig. 2, an FHIR Repository resides at the
core of the architecture as the health data repository. FHIR33
is a next generation standards framework created by HL7.
FHIR application programming interfaces (APIs) are built
from a set of modular components called “Resources.” Plug-
ging into FHIR APIs, these resources can easily be assembled
into working systems that solve real-world clinical and
administrative problems at a fraction of the price of existing
alternatives. Utilizing the HL7 FHIR standard within the data
source facilities provides support and is an enabling factor for
data FAIRification in many aspects as follows:
• HL7 FHIR assigns a globally unique and persistent logical
identifier (i.e., Object Identifier) to each resource (findable).
• The location of a resource instance is an absolute Uniform
Resource Identifier (URI) constructed from the server base
address at which the instance is found, the resource type
and the logical ID, such as http://test.hl7.fhir.org/rest/Pa-
tient/123 (where 123 is the logical Id of a patient re-
source). When the location is an Hypertext Transfer
Protocol (HTTP) address, this address can generally be
used to retrieve or manipulate the resource (accessible).
• HL7 FHIR provides a “formal, accessible, shared, and
broadly applicable”way to represent (health) information
(interoperable).
• Each HL7 FHIR resource includes a rich set of attributes to
describe the most relevant data and metadata; a formal
extension mechanism is also specified by that standard to
cover additional requirements (reusable).
Fig. 2 An architecture implementing the FAIRification workflow for health data. The numbered red circles refer to FAIRification workflow steps
that are explained in the text. FAIR, findability, accessibility, interoperability, and reusability; FHIR, fast health care interoperability resources.
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• FHIR enables to define a Semantic Model through FHIR
profiles which are a set of constraints on a resource
represented as a structure definition.
• Data versioning is an inherent functionality that ships
with FHIR. Data provenance is implementedwith the FHIR
provenance resources.
Around the FHIR Repository, there exist several compo-
nents for transforming the raw data into FAIR data. These
components are expected to operate in the same order as the
FAIRification workflow. Detailed information about these
components are provided in the following subsections.
Data Curation Tool and Data Validation Tool
According to the FAIRification workflow for health data, after
raw data analysis, data curation and validation are performed
first. The aimofDataCuration andValidation tool is to not only
increases the quality of data for research purposes but also
made the data accessible through a standard API, that is, HL7
FHIR, so that interoperability of FAIR data can be satisfied.
Data curation and validation of health data in raw format
canbeperformed inseveral steps that are illustrated in►Fig. 3.
1. The data manager connects to the data source and with the
helpofdatasourceanalyzer looksat themetadata in thedata
source. Various data sources with different data formats can
be connected including comma-separated values (CSV) files
and relational databases with custom information models,
as well as standard interfaces, such as picture archiving and
communication system (PACS) and integrating the health-
care enterprise (IHE) cross-enterprise document sharing
(XDS) profiles47which provide digital imaging and commu-
nications inmedicine (DICOM)48 and the Consolidated CDA
(C-CDA)49 formatted medical data respectively.
2. The Data Manager maps the source data elements (the
metadata, i.e., patient date-of-birth field) to the target CDM
(the predefined FHIR profile) through Metadata Mapper.
3. Since the CDM is described as a FHIR profile, Metadata
Mapper communicates with the FHIR Repository to show
the target data elements (the resource types andattributes)
to the Data Manager associated with the FHIR repository.
4. Once the mappings are set, data are transferred to Data
Transformer.
5. Data Transformer accesses the data source and retrieves
the original data.
6. Data Transformer transforms the data to the FHIR Reposi-
tory, conforming to the CDM, based on the givenmappings.
7. Data Validator is an inherent part of the FHIR Repository.
During the transformation, it validates each transaction in
termsof conformance to the defined FHIRprofile. Due to this
validator, it is not possible to insert resource instances
without required fields. This validation ensures that the
FHIRRepositorywill alwaysservesufficientdata for research
purposes, for example, running data mining algorithms.
Health Data Deidentification Tool
The Health Data Deidentification tool is designed to work on
HL7 FHIR API so that it can be used on top of any standard FHIR
Fig. 3 The architecture of Data Curation and Validation tool. The numbered red circles show the sequence of steps explained in the text to
curate and validate the health data. C-CDA, the consolidated clinical document architecture; CSV, comma-separated values; DICOM, digital
imaging and communications in medicine; FHIR, fast health care interoperability resources; IHE XDS, integrating the healthcare enterprise cross-
enterprise document sharing; PACS, picture archiving and communication system.
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Repository as a toolset for data deidentification, anonymiza-
tion and related actions. The component is expected to access
FHIR resources, present metadata to the Data Manager, guide
the Data Manager about the deidentification configuration to
be applied and then output the processed FHIR resources. The
resulting FHIR resources are deidentified/anonymized based
on the configuration that the Data Manager provided.
►Fig. 4 depicts the internal structure of Health Data
Deidentification tool. It is assumed that the previous step
(s) results in a FHIR Repository which contains the data as
FHIR resources. Based on the presented subcomponents, a
general execution scenario can be described as follows:
• Curated and validated FHIR data are analyzed by the
Metadata Analyzer. In this subcomponent, availablemeta-
data are presented to the Data Manager so that the Data
Manager can get detailed information about the data
residing in the FHIR Repository. For example, demograph-
ic data of a patient can be described through attributes
such as date of birth, gender, and nationality.Medical data
observations can be described through specific attributes,
for example, in case of blood pressure observation, those
would be diastolic and systolic attributes.
Algorithm suggestion service comes into play to suggest
standalone algorithms (such as pseudonymization, fuzz-
ing, and generalization) to be applied to the analyzed
attributes to deidentify/anonymize. This service main-
tains an Algorithm Repository which includes a wide
range of well-established algorithms.
• Algorithm suggestion service makes use of Deidentification
Algorithm Repository to suggest algorithm. The DeIdentifi-
cation Algorithm Repository is a separate component that
includes different DeIdentification Algorithms. Therewill be
common algorithms such as generalization and substitution.
• After algorithm suggestions are generated, the Configura-
tion Manager prompts the Data Manager for the final
decision. At this step, to ensure privacy preserving data
publishing, the configuration manager will enable the
Data Manager to run several algorithms such as k-ano-
nymity, l-diversity, and t-closeness to assess the anonym-
ity of the dataset, and when not satisfied, change the
deidentification algorithms selected for the necessary
data elements. The Data Manager will finalize configura-
tion to select which algorithms will be used for which
attributes, with which parameters.
• The Deidentification Engine receives the configurations
from the ConfigurationManager and connects to the FHIR
Repository to convert the raw data. Data are deidentified
according to those configurations.
• De-identified data are saved into the FHIR Repository
again. Hence, FHIR resources which carry sensitive infor-
mation are transformed into FHIR resources which do not
carry sensitive information anymore.
Semantic Enrichment Tool
The Semantic Enrichment tool incorporates domain relevant
medical terminologies within the FHIR CDM. It can be
integrated on top of any FHIR Repository accessing the
resources through the Semantic Analyzer and providing
the corresponding mappings using a Terminology Service,
which follows the specifications of HL7 FHIR. Finally, the FAIR
data objects are stored again allowing the interpretation of
Fig. 4 The architecture of Health Data Deidentification tool. The numbered red circles show the order of health data de-identification steps that
are explained in the text.
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concepts that have related meaning as if they were in the
same “language.”
►Fig. 5 depicts the subcomponents of the Semantic
Enrichment Tool. The workflow is as follows:
1. Curated, validated, and deidentified FHIR resources are
gathered by the Semantic Analyzer.Metadata and data are
retrieved and processed to identify the medical concepts
and associated metadata.
2. All the resources are filtered out and those with no
correspondence to the common terminology are passed
to the Semantic Mapper.
3. The Semantic Mapper receives all the concepts and links
the suitable translations using the FHIR-based Terminol-
ogy Server which provides FHIR ConceptMap,50 resources
for each of the needed translations. It also stores all the
code systems (source and destination).
4. Once all themappings are generated, the Semantic Engine
fills in all the FAIR data objects with all the available
translations, as the FHIR standard permits including
multiple vocabularies in the same resource.
5. The data are stored back in the FHIR Repository.
Discussion
The FAIR data principles1 aim to ensure that research outputs
are shared in a way that enables and enhances reuse by
humans and machines. Although FAIR emerged from a work-
shop in the life science community, the principles are applica-
ble to datasets and metadata from all disciplines. FAIR echoes
previous statements on open data and curation such as the
Organization for Economic Cooperation and Development
(OECD) principles and guidelines for Access to Research Data
from Public Funding51 and the Royal Society Science as an
Open Enterprise reports.52 The Royal Society report put for-
ward the notion of “intelligent openness” where data are
accessible, intelligible, assessable, and usable. FAIR proposed
similar principles in a more arresting and memorable articu-
lation of the concepts, and that allowed it to gain significant
traction and uptake internationally. The European Commis-
sion encouraged implementation of FAIR in the call for pro-
posals of theHorizon 2020Work Program 2018 to 2020 under
the pillar health, demographic change, andwellbeing.53 In the
same year, the NIH announced a funding opportunity for the
data commons pilot phase,54 which also supported the appli-
cation of the FAIR data principles to the research outputs. A
similar example can be found in Australia,55 and this policy is
already being developed in some countries of Africa, in this
case with the support of the Committee on Data International
Science Council (CODATA) initiative.56 This leads to a land-
scape in which only those researchers able to commit to the
FAIR principles will have the opportunity to develop research
projects fundedbypublic agencies. Therefore, researchersmay
benefit in the coming years from a common framework that
supports the FAIRification process.
Considering the health-specific challenges and available
research in this area, this paper proposed fine-tuned and
brand-new steps within the FAIRification workflow and pre-
sented an implementation architecture. The proposed archi-
tecture utilizes anHL7 FHIR Repository for native FAIR support
acting as an enabling factor for data FAIRification. FHIR specifi-
cation offers modular components called resources. The char-
acteristics of these resources can be oriented to achieve
compliance with FAIR guidelines. For example, FHIR uses
globally unique identifiers and can assign other identifiers.
The data elements described in FAIR correspond to concepts
and (meta)data objects modeled, as FHIR resources and de-
scribed with rich metadata and context information. In FHIR,
resources are retrievable via open APIs, that is, absolute URIs
and standard Representational State Transfer (REST) protocols.
All these capabilities align with FAIR principles. Steps like
“Make data linkable,” “License attribution,” “Data versioning”
and “Publishing” refer to these inherent capabilities of FHIR.
Moreover, introduced steps such as “Data curation & valida-
tion” and “Data de-identification & pseudonymization” toolset
Fig. 5 The architecture of Semantic Enrichment Tool. The numbered red circles refer to the order of execution that are explained in the text.
FHIR, fast health care interoperability resources.
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havebeendesignedontopofageneric FHIRRepository tomake
it interoperable and reusable. We claim that our architectural
design follows theFAIRificationworkflow,while implementing
the revised workflow appropriate for health data.
Musen et al57 are developing an open source workbench
based on semantic web technologies to support open science
within the center for expanded data annotation and retrieval
(CEDAR) initiative.58 This workbench provides a pipeline for
authoring experimental metadata in biomedical sciences
through the use of templates. This workbench only provides
support for metadata authoring and management, and, to
the best of our knowledge, it does not provide functionalities
for curating, deidentifying, or versioning data. The Dutch
Techcentre for Life Sciences is currently developing a set of
tools to implement the FAIR data principles and apply them
to the rare disease datasets collected by the RD-connect
platform.59 This toolkit is based on the FAIRification process
proposed by GO FAIR, and built upon the OpenRefine soft-
ware (http://openrefine.org/). This toolkit allows for creating,
publishing, finding, and annotating FAIR datasets. However,
it seems to not support the deidentification of samples, so
this stepwould need to be performed outside the toolkit. The
application of deidentification methods to the datasets may
not be necessary for those samples gathered during the
research process, as it is a common practice to replace
personal identifiers with artificial IDs. However, when deal-
ing with datasets derived from routine care, this step turns
out mandatory so patient’s privacy can be preserved.
For research purposes, data are gathered upon the signa-
ture by the data donor of an informed consent for that
specific research. In a routine care environment, consent is
usually given for health care purposes only, and secondary
use of the personal information gathered is generally pro-
hibited. However, GDPR acknowledges that these data can be
reused without consent for reasons of public interest in the
areas of public health (Art. 9). Regarding reusing this data in
scientific research, GDPR permits further processing of per-
sonal data when the principle of data minimization is
respected. This processing does not permit the identification
of data subjects and requires that appropriate safeguards
exist (such as, for instance, pseudonymization of the data)
and the purpose of the processing is compatible with the
original purpose for data collection (Art. 89.1, Recitals 156
and 157).16 The FAIRification workflow proposed in this
contribution supports these legal provisions as much as
possible by providing the tools needed to FAIRify specific
subsets of raw datasets to comply to the minimization
principle and to deidentify or pseudonymize the datasets.
Conclusion
In this work, the FAIRification process proposed by GO FAIR
has been examined and adapted to health data requirements
by applying restrictions on existing steps and introducing
new steps for requirements elicited after performing a
comprehensive analysis of technical, ethical, and legal impli-
cations that reusing health data for biomedical research
purposesmay have. As a result of this analysis, a FAIRification
workflow is proposed to be applied in the health domain
taking into account-specific functionalities for data curation,
data validation, data deidentification/pseudonymization,
and data versioning. The technological architecture of these
new components added to the FAIRification process has been
designed, and the HL7 FHIR standard has been proposed for
their implementation, as this standard has shown to be
suitable for complying with the FAIR data principles.
Routine health care datasets or data resulting from health
research can be FAIRified, shared and reusedwithin thehealth
research community following the FAIRificationworkflowand
the associated architecture designproposed by this paper. This
methodology leverages health data resources so that knowl-
edge discovery can be accelerated, while reducing biases and
enhancing the strength and quality of scientific evidence.
Additionally, this workflow supports a practical implementa-
tion of transparency, openness, and reproducibility to support
the pillars of Open Science and Responsible Research and
Innovation strategies promoted by the European Commission.
On top of that, the data science communitywill be able to take
advantage of the availability of these data resources to develop
advanced analytical solutions and provide data-driven inno-
vative services thatwill enable a seamlesslyapplicationofnew
evidence into the clinical practice.
Themain limitation of this contribution is that the proposed
FAIRificationworkflowandthearchitecturedesignhasnotbeen
tested in real settings yet. However, to the best of our knowl-
edge, analyzing the health-specific requirements for various
used cases, adjusting the FAIRification workflow for those
specific challenges after performing thorough analyses, such
asadetailedanalysis of theregulatory framework in theEU, and
designing a software architecture utilizing a well-established
international standard is the first attempt towardmethodolog-
ical FAIRification of health data. Yet, it should also be noted that
the workflow details and the design may be subject to change
during the software development and deployment stage.
The software following the proposed architecture design is
under development on Github following the open-source
philosophy (https://github.com/fair4health). Future work
will be focused on the practical implementation of the FAIR-
ification workflow and on the development of used cases to
demonstrate the impact that such strategymay have onhealth
research and routine health care. More specifically, it is fore-
seen to develop two prototypes: the first one will support
health researchers by addressing the identification of disease
association patterns in the general population, while the
second one will support routine healthcare through the im-
plementation of a tool able to predict the 30-day readmission
risk in patients with chronic obstructive pulmonary disease
(COPD).Bothusedcaseswillbedevelopedupon theapplication
of this FAIRificationworkflowover a federated cohort account-
ing with more than 5 million patients based on data derived
from both routine health care and health research initiatives
publicly funded.
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